{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T03:14:49Z","timestamp":1788059689020,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tvjl.2026.106819","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T14:04:57Z","timestamp":1786284297000},"page":"106819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating Sacubitril\/Valsartan's efficacy in reducing myocardial hypertrophy and fibrosis in feline models"],"prefix":"10.1016","volume":"319","author":[{"given":"Zeyao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changmin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9474-7653","authenticated-orcid":false,"given":"Cong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2026.106819_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11897-021-00501-6","article-title":"Reverse cardiac remodeling and ARNI therapy","volume":"18","author":"Abboud","year":"2021","journal-title":"Curr. Heart. Fail. Rep."},{"key":"10.1016\/j.tvjl.2026.106819_bib2","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1161\/01.CIR.0000131449.94713.AD","article-title":"Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists","volume":"109","author":"Azizi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.tvjl.2026.106819_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005565","article-title":"Sacubitril\/valsartan decreases cardiac fibrosis in left ventricle pressure overload by restoring PKG signaling in cardiac fibroblasts","volume":"12","author":"Burke","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.tvjl.2026.106819_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jvc.2020.06.002","article-title":"Atenolol in cats with subclinical hypertrophic cardiomyopathy: a double-blind, placebo-controlled, randomized clinical trial of effect on quality of life, activity, and cardiac biomarkers","volume":"30","author":"Coleman","year":"2020","journal-title":"J. Vet. Cardiol."},{"key":"10.1016\/j.tvjl.2026.106819_bib5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jvim.15122","article-title":"International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: the REVEAL study","volume":"32","author":"Fox","year":"2018","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2026.106819_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/1098612X20972058","article-title":"Clinical characteristics of cats referred for evaluation of subclinical cardiac murmurs","volume":"23","author":"Franchini","year":"2021","journal-title":"J. Feline. Med. Surg."},{"key":"10.1016\/j.tvjl.2026.106819_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75757-8","article-title":"Sacubitril\/valsartan improves diastolic left ventricular stiffness with increased titin phosphorylation via cGMP-PKG activation in diabetic mice","volume":"14","author":"Furukawa","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.tvjl.2026.106819_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/vetsci12030289","article-title":"Clinical-diagnostic and therapeutic advances in feline hypertrophic cardiomyopathy","volume":"12","author":"Gaia de Sousa","year":"2025","journal-title":"Vet. Sci."},{"key":"10.1016\/j.tvjl.2026.106819_bib9","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy","volume":"58","author":"Gersh","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tvjl.2026.106819_bib10","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.3390\/cimb46080517","article-title":"Genetic basis of hypertrophic cardiomyopathy in cats","volume":"46","author":"Grzeczka","year":"2024","journal-title":"Curr. Issues. Mol. Biol."},{"key":"10.1016\/j.tvjl.2026.106819_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.115.018622","article-title":"Combined angiotensin receptor antagonism and neprilysin inhibition","volume":"133","author":"Hubers","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.tvjl.2026.106819_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/01.RES.0000117070.86556.9F","article-title":"B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation","volume":"94","author":"Kapoun","year":"2004","journal-title":"Circ. Res."},{"issue":"118","key":"10.1016\/j.tvjl.2026.106819_bib13","first-page":"54818","article-title":"A model of cardiac remodeling through constriction of the abdominal aorta in rats","author":"Ku","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.tvjl.2026.106819_bib14","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1038\/s41467-025-62203-0","article-title":"Effects of sacubitril\/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial","volume":"16","author":"Lee","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tvjl.2026.106819_bib15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.addr.2021.03.021","article-title":"Cardiac fibrosis: myofibroblast-mediated pathological regulation and drug delivery strategies","volume":"173","author":"Liu","year":"2021","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.tvjl.2026.106819_bib16","article-title":"LCZ696 alleviates myocardial fibrosis after myocardial infarction through the sFRP-1\/Wnt\/\u03b2-catenin signaling pathway","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.tvjl.2026.106819_bib17","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/jvim.15745","article-title":"ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats","volume":"34","author":"Luis Fuentes","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2026.106819_bib18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cvsm.2017.05.002","article-title":"Asymptomatic hypertrophic cardiomyopathy: diagnosis and therapy","volume":"47","author":"Luis Fuentes","year":"2017","journal-title":"Vet. Clin. N. Am. Small Animal Pract."},{"key":"10.1016\/j.tvjl.2026.106819_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tvjl.2026.106819_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.892460","article-title":"Molecular mechanisms of sacubitril\/valsartan in cardiac remodeling","volume":"13","author":"Mustafa","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tvjl.2026.106819_bib21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3390\/biology11071017","article-title":"Roles of natriuretic peptides and the significance of neprilysin in cardiovascular diseases","volume":"11","author":"Nakagawa","year":"2022","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.tvjl.2026.106819_bib22","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1016\/j.jvc.2015.03.008","article-title":"Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study)","volume":"17","author":"Payne","year":"2015","journal-title":"J. Vet. Cardiol."},{"key":"10.1016\/j.tvjl.2026.106819_bib23","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(09)61966-8","article-title":"Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study","volume":"375","author":"Ruilope","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tvjl.2026.106819_bib24","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.3892\/mmr.2021.12315","article-title":"Sacubitril\/valsartan (LCZ696) reduces myocardial injury following myocardial infarction by inhibiting NLRP3-induced pyroptosis via the TAK1\/JNK signaling pathway","volume":"24","author":"Shen","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.tvjl.2026.106819_bib25","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tvjl.2026.106819_bib26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cardfail.2020.04.011","article-title":"Sacubitril\/valsartan improves left ventricular function in chronic pressure overload independent of intact cyclic guanosine monophosphate-dependent protein kinase I alpha signaling","volume":"26","author":"Tam","year":"2020","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.tvjl.2026.106819_bib27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijcard.2014.08.032","article-title":"Natriuretic peptides and cardio-renal disease","volume":"176","author":"Volpe","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.tvjl.2026.106819_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15851-2","article-title":"A feline HFpEF model with pulmonary hypertension and compromised pulmonary function","volume":"7","author":"Wallner","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tvjl.2026.106819_bib29","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1161\/01.CIR.96.11.4065","article-title":"Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation","volume":"96","author":"Weber","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.tvjl.2026.106819_bib30","article-title":"Protective effects of sacubitril\/valsartan on cardiac fibrosis and function in rats with experimental myocardial infarction involves inhibition of collagen synthesis by myocardial fibroblasts through downregulating TGF-\u03b21\/Smads pathway","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326002753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326002753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:19:35Z","timestamp":1788056375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023326002753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"alternative-id":["S1090023326002753"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106819","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating Sacubitril\/Valsartan's efficacy in reducing myocardial hypertrophy and fibrosis in feline models","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106819"}}